In short
Episode is a Bloomberg Law segment with two main topics: (1) Google’s antitrust remedy ruling in the search monopoly case, and (2) calls for Robert F. Kennedy Jr. to resign from HHS/CDC leadership changes.
Guests and backgrounds
Harry First, NYU Law School antitrust professor; Harry Nelson, healthcare attorney at Leach Tishman Nelson Hardiman (second segment).
Key claims
Judge Amit Mehta rejected the government’s most severe remedy—forced divestiture of Chrome—while ordering narrower concessions: sharing certain online search data with rivals and ending exclusive distribution contracts (Google can still pay for defaults). First argues the decision is “win-win” for both sides, but policy-wise conservative and heavily influenced by expectations that generative AI will erode search dominance.
Notable examples
mentions Safari searches declining and users going to ChatGPT/Perplexity; references Microsoft remedy standards.
Second segment claims
HHS staff allege politicization, NIH/CDC leadership cuts, and COVID vaccine guidance changes that reduce eligibility (65+ and high-risk only) and may raise costs. Nelson cites removal of CDC vaccine advisory structures and firing/attempts involving CDC leadership; notes possible lawsuits and congressional oversight.
Written by AI. May contain mistakes. Listen to the episode to check what was said.
Chapters
Tap a time to open that second in VOGoogle's Antitrust Case Overview
0:31 to 0:59
Discussion on the recent ruling in Google's antitrust case and its implications.
“Discover a spectacular island destination with crystal blue seas, endless sunshine, and the cool Bahamian breeze.”
Google's Antitrust Case Overview
1:39 to 4:00
Discussion on the recent ruling in Google's antitrust case and its implications.
“In the biggest tech antitrust case in three decades, Google avoided a breakup after a D.C.”
Judicial Conservatism in Rulings
4:00 to 6:28
Analysis of Judge Mehta's conservative approach and its impact on the case.
“But we've now passed the point where the question will be, will we get competition?”
Impact of AI on Google's Dominance
6:28 to 8:55
Exploration of how AI may influence competition and the search engine market.
“And that stems from actually the Microsoft case, which is much the template for the complaint that the government filed and for the government's theories.”
Data Sharing and Competition
8:55 to 11:12
Discussion on Google's obligation to share data and its implications for competitors.
“We'll just control AI and we won't have moved to new competition, but we'll have a different product.”
Challenges in Judicial Remedies
11:12 to 12:12
Examination of the difficulties judges face in determining effective antitrust remedies.
“More than once now, it's not just a snapshot, but the cap yet to be determined by this technical committee that the decree is going to set up.”
Google's Search Engine Shakeup
14:00 to 14:49
Learn about the federal judge's ruling on Google's search engine and its implications.
“and doesn't charge a cent for businesses to access their own data.”
The Judge's Approach to Remedies
14:49 to 16:55
Discussion on Judge Mehta's ruling and future remedy proposals in the antitrust case.
“A federal judge ordered a shakeup of Google's search engine in an attempt to curb the power of an illegal monopoly, while rejecting the government's attempt to break up the company and impose other restraints.”
Paying for Default Search
16:55 to 18:38
Examining Google's payment strategy for default search settings and its legal implications.
“You know, tell me why you asked for this particular thing, Google, please explain it.”
Impact of Defaults on User Behavior
18:38 to 21:18
Insights into how default settings influence user decisions and Google's position.
“If you have an exclusive, you get revenue shares, things like that.”
Show all 25 chapters
Appeal Prospects and Future Steps
21:18 to 22:55
Exploration of potential appeals and the future of the antitrust case against Google.
“But at the moment, Google can still pay for default.”
Comparison with Other Antitrust Cases
22:55 to 24:24
Discussion on the strategies and outcomes of previous antitrust cases, particularly Microsoft.
“I mean, do you think that his opinion is conservative enough to survive the D.C.”
Upcoming Google Advertising Case
24:24 to 26:53
Overview of another antitrust case involving Google's online advertising and its potential outcomes.
“you're asking for too much, you know, we need to be modest, etc, etc.”
Calls for Kennedy's Resignation
29:14 to 30:18
Current and former health officials demand the resignation of RFK Jr. over health concerns.
“signed a letter calling for Health Secretary Robert F.”
Concerns Over Public Health Policy
30:18 to 31:31
Discussion on the issues raised by health professionals regarding the CDC under Kennedy.
“that they're going to be able to accomplish that.”
Funding Cuts and Medical Research
31:31 to 32:56
Exploration of the impact of funding cuts on medical research under Kennedy's leadership.
“Well, I mean, the cuts on medical research have mostly come through National Institute of Health NIH grants.”
Changes in Vaccine Guidance
32:56 to 34:25
Details on new COVID vaccine access policies and their implications for the public.
“moves that RFK and his people wanted to make.”
State Responses and Congressional Action
34:25 to 35:52
Potential state actions and congressional oversight regarding public health changes.
“This was specifically a COVID policy, but it's clear that there are going to be significant limits on the flu vaccine as well.”
Senate Oversight and RFK's Confirmation
35:52 to 37:11
Discussion on the Senate's role in overseeing health policies and RFK's confirmation.
“you know, a high priority issue that's concerning people.”
Concerns About New CDC Director
37:11 to 38:38
Introduction of Jim O'Neill as new CDC director and the concerns it raises.
“But, you know, Bill Cassidy and he was the Louisiana Republican senator who delivered the key vote to confirm Kennedy.”
RFK Jr.'s Health Policy Approach
38:38 to 39:59
Analysis of RFK Jr.'s health strategies and their alignment with Trump's administration.
“O 'Neill, first of all, was a deputy to RFK already and seems to be aligned with his vision that he's just rebuilding the CDC.”
RFK's Polarizing Figure in Politics
39:59 to 41:05
Insight into RFK Jr.'s popularity and polarizing stance within public health.
“We've seen, you know, President Trump posting on Truth Social urging pharmaceuticals to release more data and sort of, you know, claiming that there's some kind of hidden story about vaccine efficacy.”
Positive Aspects of RFK's Initiatives
41:05 to 42:11
Discussion of the positive health initiatives proposed by RFK Jr. amidst criticism.
“RFK is obviously a very polarizing figure.”
Vaccine Policy and COVID Preparedness
42:11 to 44:05
Discussion on the impact of vaccine policies and the risks of COVID resurgence this winter.
“He's calling attention to chronic disease.”
Vaccine Policy and COVID Preparedness
44:30 to 45:09
Discussion on the impact of vaccine policies and the risks of COVID resurgence this winter.
“I'm June Grosso, and you're listening to Bloomberg.”
Transcript
Automatic transcript. May contain errors.0:00Everyone's talking about how AI is transforming work, especially in sales. While the landscape shifts, one thing remains the same, the thrill of closing a deal. Whether it's a gong or a confetti machine, every team has its celebration rituals. Adio is designed for that moment. It's the agentic CRM that turns customer signals into actionable insights, helping you close deals faster with revenue agents and automations working around the clock. You'll have everything you need to scale your go-to market efforts. Elevate your wins with Adio. Start your free trial at adio.com slash iHeart. Discover a spectacular island destination with crystal blue seas, endless sunshine, and the cool Bahamian breeze.
0:39Bahamar, located in Nassau, Bahamas, offers your choice of three luxury hotels, over 45 fine dining and nightlife venues, John Batiste's all-new jazz club, the Caribbean's most luxurious casino, and one-of-a-kind experiences for the entire family. like our 15-acre tropical water park, wildlife sanctuary, world-class golf course, and so much more. Visit Bahamar.com today. They're back live across North America.
1:12Guns N' Roses Tour 2026.
1:18Get tickets now at LiveNation.com. In the heart.
1:27Don't miss Guns N' Roses.
1:33This is Bloomberg Law with June Grosso from Bloomberg Radio. In the biggest tech antitrust case in three decades, Google avoided a breakup after a D.C. federal judge ruled against the government's most severe proposals for remedies. including a forced sale of its Chrome browser. Judge Ahmet Mehta had already found in August of 2024 that Google illegally dominated the search market by paying more than$26 billion to Apple and other companies to make its search engine the default option on smartphones and web browsers. Tuesday's ruling was all about the fix, and Google will have to make some concessions, including sharing online search data with rivals and ending exclusive contracts for distribution.
2:29My guest is antitrust law expert Harry First, a professor at NYU Law School. So on its website, the Department of Justice says, Department of Justice wins significant remedies against Google. But this falls far short of the severe remedies that the government wanted. How much of a setback is it for the government in its attempt to curb the power of the biggest tech companies? Well, you know, people often talk about things as being a win-win and that that's a good thing. So I think that the judge's decision is a win-win, but not a good thing. So why is it a win-win? Because the Justice Department and the states get something and Google gets more by there not being more.
3:21So I view it as win in sort of eight-point type on the government side. and win in sort of 16-point type on Google's side. So here's what I mean. It's not a significant victory for the Justice Department. They did win some things, and maybe that will help bring some competition into search. But I think Google won a lot by not losing very much. They get to keep Chrome. A lot of the remedies that the department asked for and got even were cut down, circumscribed, diminished. And, you know, whether what the judge did will end up changing the search business, I doubt, but who knows. But we've now passed the point where the question will be, will we get competition?
4:15And the question will just be, is Google complying with the decree? Of course, all of that comes after a round of appeals. So there's much more to this. But in terms of, you know, the overall feeling about what we've done, I think it's, you know, from a public point of view, a disappointment. So the big headline was always, will Google be forced to sell Chrome? Will it have to divest? So Google doesn't have to do that. Why did Judge Mehta decide not to make Google divest Chrome? So this is the second point that pervades Judge Mehta's decision, rightly in a legal sense, but I think not so correct from a policy point of view and really where the law ought to be.
5:06So this is in many ways a very conservative opinion. It's the judge expressing what judges often express is that, you know, they understand the limits of who they are, what the institution can do, and what they want to do on an ongoing basis. So they're conservative about this. And here the government's plaintiffs are asking them to do some pretty strong restructuring of one of the superstar firms in the United States. So you got to be a little modest. Now, the judge backs up his modesty with a lot of quotations from the Court of Appeals and recently from the Supreme Court in a different antitrust case, opinion written by Justice Gorsuch, which counsels, let's be careful a little bit.
5:58So the ask that Crone be divested, structural relief is something that the D.C. Circuit itself, remember Judge Mehta is a district court judge overseen by a court of appeals from the D.C. Circuit, District of Columbia Circuit. So he is required to follow the law from that circuit. The law from that circuit on remedies is actually pretty conservative and cautious. And that stems from actually the Microsoft case, which is much the template for the complaint that the government filed and for the government's theories. So, you know, they said, well, when it comes to structural relief, restructuring, reorganizing a company, you really need some strong proof before you do that.
6:48You need to watch out. And so he took those admonitions to heart and just didn't find enough to overcome that sort of a presumption that, you know, you don't do this unless you really have to do it for effective relief. And this then goes to the second part that maybe the government didn't make an effective enough case for divesting Chrome and maybe made it seem too easy. So stuck with all of that, he backed away from it. How much did AI play into his decision? So that's maybe the real lead, which we're now burying. I think his decision is all about AI, frankly. And I think that he's betting, and many in the industry, and if you listen to some of the news shows, are just simply betting that AI is going to replace search as we know it with something else that's not search as we know it, or maybe as you and I know it, but just simply getting information.
7:53And that Google search, that product, no matter what he does in this opinion, is going to be eclipsed by some AI product. And I think that that permeates. I think that he views generative AI as coming to the rescue of competition. Yeah, some say it's already eroding Google's dominance. The data seem to show, he mentions this in his opinion, that searches on Safari have decreased. People seem to be going directly to chat GPT or perplexity or some of these other AI assistant things and just getting information that way. And this is the destructive force of innovation, as the economist Joseph Schumpeter talked about many years ago.
8:46So maybe he's right. And, you know, that may mean that sort of didn't matter what he did so long as AI lives. But of course, the worry is that we'll just replicate the current structure of the tech platform superstar firms. We'll just control AI and we won't have moved to new competition, but we'll have a different product. He's ordering Google to share data with rivals to open up competition in online search. Google has to share some of the data with competitors, but not some of its most important data, would you say? Well, here again, it's hard to say exactly what are important data. You could say all of the data are important, the more the more.
9:33But, you know, this particularly involves the search index, which is something that Google has done really well. And the government in some ways didn't ask for as much as it could, which would have been a license to the index itself. What they wanted is some help with the data so competitors could build an index. And even with that, the judge cut down the kinds of data that will be required to be disclosed. And to me, even more importantly, the timing of the disclosure. So for some of these data, it's a one-time snapshot, which strikes me as, you know, the judge calls it a kickstart for competition.
10:17Yeah, like a kick in the rear. I don't know. So, you know, a one-time thing for some very important parts of some basic information to help them put together a better index of the web. There's an awful lot of information out there, and indexing it is critical for an effective search engine. And, you know, when it comes to sort of this user side data, the click and query, you know, what we do when we get free search is create data that's worth a heck of a lot of money, for which we don't get paid, we being you and me and all the other users. But these data, here again, the judge cuts down the request, gives some amount of the request, and then sort of puts on some limits yet to be decided about how often this will be disclosed.
11:14More than once now, it's not just a snapshot, but the cap yet to be determined by this technical committee that the decree is going to set up. So, I don't know, it's hard for me to say exactly, will this enable competitors to really get an effective competing search engine, or will it not quite be enough? And in some ways, this goes to what I've always viewed as the underlying problem with these decrees is a judge trying to say what competitors need to succeed instead of a judge saying, don't ask me, just come back. You know, Google, just come back and let me know whether there's competition or not.
11:58And if there isn't, we're going to have to do something more about it. you know, trying for judges or even the Justice Department, which apparently at least is still made up of some lawyers, you know, trying to design these remedies is tough. And you can feel it with what the judge has written in this opinion. It's hard. And trying to figure out what the effect is going to be, I mean, he said at the beginning, you know, I don't have a crystal ball. Other judges have used that worry as well when being asked to predict effects in future markets. Coming up next on the Bloomberg Law Show, I'll continue this conversation with NYU law professor Harry First.
12:38Google has already said it's going to appeal. Will Judge Meta's decision stand up? I'm June Grosso, and you're listening to Bloomberg. Everyone's talking about how AI is transforming work, especially in sales. While the landscape shifts, one thing remains the same, the thrill of closing a deal. Whether it's a gong or a confetti machine, every team has its celebration rituals. Adio is designed for that moment. It's the agentic CRM that turns customer signals into actionable insights, helping you close deals faster. With revenue agents and automations working around the clock, you'll have everything you need to scale your go-to market efforts.
13:13Elevate your wins with Adio. Start your free trial at adio.com slash iHeart. Innovation is what gets your business to market. And Wasabi is designed to give every business a shot at competition. How? Break free from skyrocketing storage costs and unpredictable egress fees from old and top-heavy legacy providers. You know, the big guys. Wasabi is the world's hottest cloud storage company and the go-to provider for professional and collegiate sports teams and leagues around the world. And here's why. Innovation. From Wasabi's AI-enabled intelligent media storage, Wasabi Air, to the industry's only cloud storage service with triple protection against cybercriminals, data deletion and ransomware, the world's top companies trust Wasabi.
13:59Remember, Wasabi is up to 80 % less than market competition and doesn't charge a cent for businesses to access their own data. Wasabi, another championship story. Check them out for free at wasabi.com. Wasabi Hot Cloud Storage, proud partner of iHeart Podcast Network. Discover a spectacular island destination with crystal blue seas, endless sunshine, and the cool Bahamian breeze. Baja Mar, located in Nassau, Bahamas, offers your choice of three luxury hotels, over 45 fine dining and nightlife venues, Jean-Baptiste's all-new jazz club, the Caribbean's most luxurious casino, and one-of-a-kind experiences for the entire family, like our 15-acre tropical water park, wildlife sanctuary, world-class golf course, and so much more.
14:47Visit BajaMar.com today. A federal judge ordered a shakeup of Google's search engine in an attempt to curb the power of an illegal monopoly, while rejecting the government's attempt to break up the company and impose other restraints. The 226-page decision made by D.C. federal judge Amit Mehta will likely ripple across the technological landscape at a time when the industry is being reshaped by artificial intelligence. as companies like ChatGPT and Perplexity try to upend Google's long-held position as the Internet's main gateway. Those innovations and competition reshaped the judge's approach to the remedies in the nearly five-year-old antitrust case.
15:37Judge Mehta wrote, Unlike the typical case where the court's job is to resolve a dispute based on historic facts, Here the judge is asked to gaze into a crystal ball and look to the future. Not exactly a judge's forte. I've been talking to antitrust law professor Harry First of NYU Law School. So Harry, the judge is directing both sides to come back by September 10th with a new remedy proposal consistent with his ruling or file a status report outlining any disagreements. Do you expect anything real from that? I think what he's looking for is he's got to write this down. He's got to enter a decree that has definitions, that has specific language, that's understandable.
16:22I mean, the first challenge is figuring out sort of what to accept in the party's proposals. But the second challenge is the drafting of that decree. I think that's what he's looking for next. You know, give me your actual proposed decrees. The parties have done that. They have proposed final judgments, but now they've got to take, here's what he's ordered, and I think he wants language now. He also hinted at some fallback potential remedies. One of the problems, I think, that he faced, and it surfaced in a question that he ended up posing on the record, which is pretty rare. You know, tell me why you asked for this particular thing, Google, please explain it.
17:08And he had a final hearing, but as he sits down to start to write the opinion, he's thinking, hmm, I've got an interesting, different idea here that no one's proposed to me. Maybe you should think about it. So there's sort of some version of like conditionality, maybe on payments for, you know, not allowing certain kinds of payments for, you said you can make any kinds of payments, but maybe there's a fallback position. Maybe they had a fallback position for Chrome that they might want to articulate now, you know, just they said, let's get rid of it, but maybe there's some fallback. So this may be an opportunity also for the parties to propose, in addition to clarifying language, some modifications for what he's imposed.
17:55So maybe that will also go on as well. So who said this, Yogi Berra? It's not over till it's over. And it was Yogi Berra. Right. Well, allegedly. Apparently he never said anything that he's supposed to have said, which is another thing. Yeah, we'll discuss that next time. Now, as far as pay to play, the judge said that this exclusive deal that Google had with Apple, where it pays it something like$20 billion a year to be the search default on iPhones, etc. So they can still do that, but it just can't be exclusive. They can pay for default, but can't keep others from, you know, putting another search bar or who knows what.
18:35But they can still pay for default. So they can pay anyone for having the default. Defaults were never exclusive. I mean, they were exclusive. So, you know, you can only out of the box if you, you know, were an original equipment manufacturer, handset manufacturer, you know, an exclusive to put the Google search bar on if you wanted other programs or, you know, an exclusive. If you have an exclusive, you get revenue shares, things like that. So maybe not that, but he basically said you can pay for defaults, which the testimony from the behavioral economist was that's the factual equivalent of a near exclusive because people don't change from defaults very often.
19:21You know, it's an old behavioral habit with which we're very familiar and with which Google's familiar. So the judge did suggest he did this in a footnote. You read the footnotes too, Harry. I'm impressed. Hey, I'm a not quite reformed law professor. And we always know you put the good stuff in the footnotes. But anyway, at least that's our version. But there is a footnote. It's note 14. And he said he could revisit the idea of a ban on paying for default, but allowing to pay for distribution. So you could say, okay, if you distribute Google search, that's fine, we'll pay you. But we can't pay you to make it the default search engine.
20:09Now, he said, nobody sort of raised this. Hello? No one raised this, so I don't know the effect. Hello? So maybe we'll get something. You could wonder whether that makes any difference, frankly, because once you distribute it, given the strength of this default in most people's experience, it may not make a difference whether you label it a default or not. If you get, you know, the Google widget, you know, on your phone particularly where it's very strong because you want to use Google search and whether it was a default or not, or whether it's a fault in your Chrome browser, which it's going to be, You'll use it, and the payment won't be for requiring it to be a default, say, on the iPhone.
20:54But Apple may still make it a default unless they're offered a better alternative, which the testimony from Eddie Q, the Apple guy involved, was that he wouldn't buy Bing for any amount of money ever, apparently. So he needs something better. And is he going to take away Google search full from Apple users? I doubt it. So there might be some modifications. But at the moment, Google can still pay for default. And here again, this was the judge's concern for the impact, in being modest sort of, the impact on, you could say, the whole ecosystem of stopping those payments. and, you know, maybe wrecking Firefox, you know, DuckDuckGo, you know, even you seem to be concerned about wrecking Apple.
21:45I didn't know that Apple was in such bad shape, but there we are. Well, the government said it's considering its next steps. I mean, I don't know what next steps it can take besides appeal, but Google has previously said it's going to appeal. So we assume it'll go to the Supreme Court, right? It could be years then, years and years before this gets implemented. Yeah, it might not go to the Supreme Court. Court doesn't have to take it. You know, who knows? The court didn't take Microsoft, for example. So maybe yes, maybe no. But the years is right. This will be a while yet. And we haven't seen but could see political interference with this.
22:26We really don't know. So there's a lot between now and then, I guess. But The liability decision, which he made more than a year ago, I guess, is that the whole bundle is subject to appeal once a final judgment is entered, which he has not done yet. So once that's done, then the parties have, you know, I think 60 days to file their notices of appeal. And then the process starts to play out in the Court of Appeals, you know, unless they start some sort of settlement negotiations or something. I mean, do you think that his opinion is conservative enough to survive the D.C. Court of Appeals? So he did a lot to try to survive review by the Court of Appeals.
23:19I mean, he relied quite heavily on key decisions, particularly the Microsoft Remedy decisions. And he also, oh, by the way, bolstered one of the potential weaknesses in the liability decision while he was at it. So I think it's not perfectly bulletproof, the aspect of letting AI companies share in some of these data. If I were Google, I would be hitting on that, whether that was, you know, not warranted, given as he started out by saying, there was nothing at the trial about AI. And there are ways of casting what he did as maybe not within the bounds of what the goal was in the trial. So there's some potential issue there.
24:07And I think it is certainly possible. I mean, I assume Google will pursue that. So I think it's a pretty, you know, I mean, it could be more conservative, I guess. It could have just giving Google what Google wanted. But it's a carefully drawn opinion. And, you know, time after time, he sort of knocks the government plaintiffs back a bit by saying, you know, you've overreached, you're asking for too much, you know, we need to be modest, etc, etc. Harry, the trial later this month, to determine remedies in a different case brought by the Justice Department, where a judge found that Google holds illegal monopolies in online advertising technology.
24:50How does that threaten Google? Is it more of the same? Well, it is a little different. There's a bit of remedy on advertising, but not very much because it's so much directed at effect on the search engine market. So directly, not so much. Indirectly, I think we have to see it because from the beginning, the Justice Department has asked for structural relief to break apart the way Google does advertising, you know, to break it up, in fact, and have them divest certain parts of its advertising stack, as they call it. So this opinion is very skeptical about this structural relief that, you know, if nothing else works, then that may be possible.
25:43But the ad tech case may be a case where, you know, it's been directed at structural relief. So that may be okay. Another aspect is how much money Google has made from advertising. So it reinforces the notion that this has been a monopolized market. So that may have some effect. It's important to note that that case is in a different federal circuit. It's not in the D.C. circuit. And it may be that the Justice Department chose to file there for a number of reasons, but one of it may be that on remedy, wanting a structural remedy, the D.C. circuit is a bad place to bring a case like that, given Microsoft.
26:24So maybe they were trying to avoid that by being in a different circuit, the Fourth Circuit. So we've yet to see, I think she's been holding up on this pending Judge Mehta's opinion on remedy. But, you know, they are fencing along on the remedies hearing in that case. So that should happen relatively soon. Yes, I googled it. And the trial is scheduled to begin on September 22nd. Thanks so much, Harry, as always. That's Professor Harry First of NYU Law School. Coming up next on the Bloomberg Law Show, more than a thousand HHS employees are calling on RFK Jr. to step down. I'm June Grosso, and you're listening to Bloomberg.
27:11Everyone's talking about how AI is transforming work, especially in sales. While the landscape shifts, one thing remains the same, the thrill of closing a deal. Whether it's a gong or a confetti machine, every team has its celebration rituals. Adio is designed for that moment. It's the agentic CRM that turns customer signals into actionable insights, helping you close deals faster with revenue agents and automations working around the clock. You'll have everything you need to scale your go-to market efforts. Elevate your wins with Adio. Start your free trial at adio.com slash iHeart. Innovation is what gets your business to market, and Wasabi is designed to give every business a shot at competition.
27:49How? Break free from skyrocketing storage costs and unpredictable egress fees from old and top-heavy legacy providers. You know, the big guys. Wasabi is the world's hottest cloud storage company and the go-to provider for professional and collegiate sports teams and leagues around the world. And here's why. Innovation. From Wasabi's AI-enabled intelligent media storage, Wasabi Air, to the industry's only cloud storage service with triple protection against cyber criminals, data deletion, and ransomware, the world's top companies trust Wasabi. Remember, Wasabi is up to 80 % less than market competition and doesn't charge a cent for businesses to access their own data.
28:31Wasabi, another championship story. Check them out for free at wasabi.com. Wasabi Hot Cloud Storage, proud partner of iHeart Podcast Network. Discover a spectacular island destination with crystal blue seas, endless sunshine, and the cool Bahamian breeze. Bahamar, located in Nassau, Bahamas, offers your choice of three luxury hotels, over 45 fine dining and nightlife venues, John Batiste's all-new jazz club, the Caribbean's most luxurious casino, and one-of-a-kind experiences for the entire family, like our 15-acre tropical water park, wildlife sanctuary, world-class golf course, and so much more.
Read the full transcript
29:11Visit Bahamar.com today. Today, more than 1 ,000 current and former employees across the Department of Health and Human Services signed a letter calling for Health Secretary Robert F. Kennedy Jr.'s resignation, accusing him of endangering the health of Americans. The new letter comes just two days after nine former directors and acting directors of the Centers for Disease Control and Prevention wrote an op-ed also condemning Kennedy for endangering every American's health. Dr. Richard Besser was one of the signees. We have grave concerns that the Secretary of Health is endangering the health of people across our nation by not letting the agency do its job, not following the science, and putting out guidance around COVID vaccine that is leading to confusion.
30:02But it appears Kennedy is not listening. He wrote in a Wall Street Journal op-ed published today that his changes are restoring trust in the CDC that was lost during the COVID pandemic. That's something he said before. I'm very confident in the political staff that we have down there now that they're going to be able to accomplish that. and ensure the competent functionality of that agency. My guest is Harry Nelson, a partner at Leach Tishman, Nelson Hardiman. Harry, explain some of the concerns that health care professionals have about Kennedy. Yeah, I think first and foremost, what they're sounding the alarm over is the politicization of public health itself.
30:49It just seems that, you know, that we're kind of in a battle where science is losing ground over ideology in steering health policy. So, you know, I think that op-ed was intended to be as public a form of rebuke for RSK and the way he's reshaping the CDC and public health policy as could be. You know, it was the vaccines last week or two, but it's going to move on to, you know, the conversation over environmental causes of autism and all the ways in which he has really become, you know, very politicized and moving away from science and kind of driving our public health policy. He's canceled medical research.
31:32How much and in what areas? Well, I mean, the cuts on medical research have mostly come through National Institute of Health NIH grants. Over a billion dollars in NIH grant cuts across different institutions. And, you know, just a massive, you know, reduction in kind of established leadership in positions that were previously not considered political. from the leadership of CDC itself, removing Susan Monares after just a few weeks on the job, to completely clearing out the advisory committee on vaccines. And so he's just done a wholesale shift on public policy in ways that we'll be experiencing the ramifications of for years to come, if not decades.
32:16What probably prompted this, the final straw, if you want to call it, is the attempt to fire Monterey. So she was just in there for a month. Didn't they know what she stood for? What happened? You know, I think essentially she was really just following sort of standard protocol at the CDC. And it was clear that there was tension escalating as there was a push from RFK and the people around him to narrow federal COVID vaccine recommendations to get rid of the standing advisory committee to start really changing the Vaccines for Children program. And essentially, it became clear that she was standing in the way of some of the very aggressive moves that RFK and his people wanted to make.
33:05RFK promised he wouldn't take vaccines away from anyone. But tell us what happened with this guidance, the recent guidance, and what it means for people who are not in those categories but want to get vaccines? I mean, so the main thing was that, you know, the FDA essentially planned the brakes, you could say, on sort of broad access to COVID boosters. Vaccines will remain available and covered for 65 and over and for younger people who have a specific risk factor, but in general are not going to be available for people under 65 without some specific risk factor. And of course, it's an issue of access.
33:44It now appears that there are a number of states in which it's going to be very difficult to get vaccines and also the cost of vaccines because the change in health policy is going to mean that insurance companies will not be doing any cost sharing on them. So vaccines will be much more expensive. It's clear that there's going to be a difficult time for people who are wanting to get vaccinated. And, you know, the real question that will come likely at the end of the next flu season that's not yet here is what the death rate, what the hospitalizations will be. I think a lot of people will be watching closely to see what the net impact of these changes is going to be.
34:24So is that for the COVID vaccine? What about flu shots? This was specifically a COVID policy, but it's clear that there are going to be significant limits on the flu vaccine as well. But this specific policy was update to eligibility for the various COVID-19, you know, vaccines you'll remember as Pfizer, Moderna, and Novavax. It's certainly going to have a broader effect on access to other vaccines, just because so many pharmacies and insurance companies are taking their lead from COVID policy for purposes of broader, like, influenza B and other flu-related shots. Is there anything that can be done, or is it just a question of, you know, Kennedy's there and that's it, unless he's fired for some reason.
35:09Obviously, we're going to see lawsuits undoubtedly and challenges to the firing of the CDC director, essentially, you know, questioning whether there's a violation of separation of powers here and whether there's any kind of retaliatory aspect to this. There certainly is the possibility that states could start enacting their own coverage mandates. We already see California and New York, Massachusetts, they're kind of moving in that direction. Congress could step in here, although it doesn't seem like that is likely to happen. The real remedy here, I think, is if the American public are upset about this, it's not only in the courts and or in Congress, it's also just by a public outcry to make it clear to President Trump and his administration that this is really, you know, a high priority issue that's concerning people.
36:00I do think there are political remedies, there are legal remedies, but the train is sort of leaving the station. And if they're going to happen, we need to see some action, you know, imminently. In this op-ed, the CDC directors called on Congress to exercise oversight authority over the Department of Health and Human Services. What can Congress do if they wanted to? Congress certainly could hold hearings. They could start to subpoena administration officials. They could certainly exercise authority to restore funding to state and local health agencies that's been cut. I mean, I think there is quite a bit that they could do.
36:40I think investigating, holding hearings, demanding accountability from RFK, from the people reporting up to him, and filling some of the funding gaps are the obvious things that they could do. So, candidly, it doesn't seem that Congress is at this moment demanding the kind of answers on everything from the vaccine policy to the leadership changes and the funding shifts that, you know, people concerned with public health might hope that they would. Well, Kennedy is going to appear on Thursday, I believe. So maybe we'll see some of that. But, you know, Bill Cassidy and he was the Louisiana Republican senator who delivered the key vote to confirm Kennedy.
37:19And I remember he said something like, I'm trusting you on vaccines. He called on HHS to indefinitely postpone its Vaccine Advisory Committee meeting on September 18th. That's not a long-term solution. It's interesting. You know, Senator Cassidy, who was chair of the Senate Health Committee and as a doctor, was someone whose vote was clearly pivotal in the confirmation, seems to be trying to walk a cautious line here. asking for oversight, transparency, postponement on some of these critical vaccine advisory meetings. He's definitely an important voice here. What's been disappointing to me has been that, you know, RFK is basically just refusing to address, you know, square on the issues.
38:04He seems to be just interested in deflecting blame and, you know, kind of trying to stay on a higher level message about problems at the CDC and a need for strong leadership. but without really getting into the nuts and bolts of vaccine policy. And frankly, there's no way to see the actions being taken now as consistent with his testimony during the confirmation hearing. He is suggesting Silicon Valley investor and entrepreneur Jim O 'Neill is the new acting CDC director. Tell us about him. Yeah, I think people are worried that Jim O 'Neill is not coming from the world of public health and science.
38:44O 'Neill, first of all, was a deputy to RFK already and seems to be aligned with his vision that he's just rebuilding the CDC. He's not expected to put any challenge forward, you know, in the name of science or the name of public health. It's likely that he's just going to be, you know, a mouthpiece for RFK and for all the changes that are already being made. But I don't think anyone who's concerned about what's going on is at all reassured by O 'Neill's selection. Does the CDC director have to be confirmed by the Senate? Yeah, the CDC director is a confirmed position. I think a lot of it will flow from how much feedback the senators are getting from their constituents.
39:25You know, it certainly is an opportunity to sort of take the pulse of where America is standing on these issues. My understanding is that he can serve six to seven months without a formal confirmation hearing. So we may see this issue pushed off until, you know, early 2026. So Trump said he would allow RFK Jr. to go wild on health care, and he certainly has done that. Are there any restrictions on what RFK Jr. can do? It's hard to see where Trump is having misgivings. I mean, you know, there certainly are areas where they were aligned. We've seen, you know, President Trump posting on Truth Social urging pharmaceuticals to release more data and sort of, you know, claiming that there's some kind of hidden story about vaccine efficacy.
40:14You know, I think it's funny because President Trump has taken pride at different points on Operation Warp Speed and the extent to which his administration brought the vaccines out in the middle of COVID. When, by the way, we had in the course of two years, we look at the data now, over a million Americans dead in the first two years of COVID. I think President Trump is largely distancing himself from RFK-specific actions and still trying to protect his vaccine legacy. I would think that there's probably some discomfort with the more aggressive aspects of RFK, but we have yet to see like a real action to sort of rein him in.
40:52Well, what was surprising to me is that they had a Gallup poll in July and Kennedy had higher favorability ratings than Trump and the vice president and others. Interesting. RFK is obviously a very polarizing figure. I mean, his Make America Healthy Again campaign has a lot of resonance. He's clearly, you know, someone who, for people who were excited about what RFK presented, he's delivering, right? You know, whereas President Trump is definitely having to walk a line, sort of affecting how people view him. But for people who buy into the public health agenda that's being carried out in this administration, to them, RFK is a hero.
41:31Okay, so we talk about the negative things. Is he doing anything positive to make America healthy again? There definitely are some good things. He's calling attention to big food and to, you know, the need for a sort of new look at nutrition as a driver of health. You know, the people who support him see him as a reformer fighting against entrenched institutions. And I think Maha, Make America Healthy Again, speaks to people who are frustrated with public health bureaucracy. But the problem is that when you look at the op-ed piece that came out, for example, I mean, the other side has a strong scientific grounding to say that he's taking risks with American health by things like dismantling vaccine infrastructure.
42:11So there are things that are positive. He's calling attention to chronic disease. He's doing, you know, good things to sort of try to create a populist focus on chronic illness in America and the way in which American health care could stand to be changed and shaken up. But I think we're seeing that he's also throwing out the baby with the bathwater on things like vaccine policy that I expect we'll see is really keeping Americans alive and out of the hospital in much larger numbers than without it. How likely is it that during the winter months we'll see a resurgence of COVID without these vaccines?
42:50I think that's a critical question, and I think we'll be watching. Obviously, nobody is hoping for bad news, but I think people are going to be watching very, very closely for the number of hospitalizations and the number of deaths. And I do think that clearly by narrowing vaccine eligibility to the 65 and older group and to people with a high risk condition, there's a bet being made that those populations are the are the most at risk and have the biggest central benefit. And on the other side is this, you know, not backed up by science that there's negative effects to vaccines for for healthier, younger Americans.
43:34And so I think everyone should be watching the numbers month by month as they get released closely this season. And certainly we should all be praying for a mild flu season, you know, not to have deadly variants of COVID, you know, all the other flus that are out there, bird flus. You know, we should obviously be hoping for the best, but we're definitely not coming into the season in a state of high preparedness if the opposite happens and if we have something deadly. Well, as you say, let's hope not. Thanks so much, Harry. That's health care attorney Harry Nelson of Leach Tishman, Nelson Hardiman.
44:10And that's it for this edition of the Bloomberg Law Show. Remember, you can always get the latest legal news on our Bloomberg Law podcast. You can find them on Apple Podcasts, Spotify and at www.bloomberg.com slash podcast slash law. And remember to tune into the Bloomberg Law Show every weeknight at 10 p.m. Wall Street time. I'm June Grosso, and you're listening to Bloomberg.
44:38When you're running a business, the best days are the ones where priorities stay on track. For midsize and large companies, risk can affect multiple parts of the organization at once, from property and liability to cyber and regulatory challenges. At that level, managing risk becomes an ongoing discipline. At the Hartford, the focus is on helping businesses manage risk before it turns into something more disruptive. And when losses do happen, that work is paired with insurance coverage shaped by years of underwriting, risk engineering, and claims experience. Learn more at thehartford.com slash risk mitigation.
45:13Policies provided by Hartford Fire Insurance Company and its property and casualty affiliates, Hartford, Connecticut. Everyone's talking about how AI is transforming work, especially in sales. While the landscape shifts, one thing remains the same, the thrill of closing a deal, whether it's a gong or a confetti machine, every team has its celebration rituals. Adio is designed for that moment. It's the agentic CRM that turns customer signals into actionable insights, helping you close deals faster with revenue agents and automations working around the clock. You'll have everything you need to scale your go-to market efforts.
45:45Elevate your wins with Adio. Start your free trial at adio.com slash iHeart. Across America, money is being abandoned. By taking a few seconds to check lift before your next ride, you can give money a better home inside your wallet save the money checklist
From the publisher
Antitrust law expert Harry First, a professor at NYU Law School, discusses a federal judge ruling that Google doesn't have to sell its Chrome web browser in an antitrust case. Healthcare attorney Harry Nelson, a partner at Leech Tishman Nelson Hardiman, discusses the calls for HHS Secretary Robert F. Kennedy Jr to step down. June Grasso hosts.
See omnystudio.com/listener for privacy information.
